These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7708231)

  • 1. [Treatment with immunomodulating drugs of patients with operated cancer. Long-term results].
    Sortini A; Di Marco L; Navarra G; Donini A; Fiorentini G; Santini M; Sartori A; Donini I
    Minerva Chir; 1994 Nov; 49(11):1101-5. PubMed ID: 7708231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymostimulin effect on the immune response in neoplastic patients submitted to surgical treatment.
    Cangemi V; Volpino P; D'Andrea N; Gentili S; Fabrizi S; Ippoliti F; Piat G
    Panminerva Med; 1993 Dec; 35(4):218-23. PubMed ID: 8202335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulation in sepsis.
    Percopo V; Taddeo F; Cobellis L; Tesauro B
    Ann Ital Chir; 1994; 65(1):45-7; discussion 48. PubMed ID: 7526756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and immunologic effects of T-activin therapy in early stage melanoma patients.
    Stanojević-Bakić N; Milosević D; Vucković-Dekić L; Sasić M; Marković L
    Neoplasma; 1996; 43(4):245-52. PubMed ID: 8931749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymostimulin effect on the immune response in pulmonary carcinoma with or without surgical treatment.
    Cangemi V; Volpino P; D'Andrea N; Gentili S; Salsano F; Rivi R; Ippoliti F; Piat G
    Panminerva Med; 1993 Dec; 35(4):224-30. PubMed ID: 8202336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thymostimulin immunoprophylaxis in elective abdominal surgery].
    Perotti F; Landi G; Primatesta F; Colombo A; David PG; Castellaro E; Baraldi U
    Minerva Chir; 1992 Jun; 47(12):1091-3. PubMed ID: 1495583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprophylaxis with thymostimulin in oncological surgery.
    Russello D; Puleo S; Succi L; Di Cataldo A; Scuideri M; Scilletta B; Di Blasi M; Guastella T; Latteri F
    J Chemother; 1989 Jul; 1(4 Suppl):1307-8. PubMed ID: 16312878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of immunomodulating treatment in patients with different degrees of immunosuppression].
    Manfè AZ; Grigoletto R; De Silvestro G; Bernante P; Faccioli AM
    Minerva Chir; 1991 May; 46(10):511-5. PubMed ID: 1922868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative infections: the use of thymostimulin (TP1) in patients at risk].
    Lai N; Lavosi V; Pinna S; Salis G; Colombo E; Vargiu P
    G Chir; 1992; 13(6-7):377-8. PubMed ID: 1389989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of immunodeficiency and postoperative infective complications in patients undergoing surgical resection for carcinoma of the colon-rectum. Clinical study on 50 cases, using thymus hormones and thymopentin in particular].
    Elia P; Lombardo G; Delpiano C; Granello M
    Minerva Chir; 1994 Jun; 49(6):575-80. PubMed ID: 7970063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymostimulin prophylaxis of postoperative infections in anergic patients.
    Farina EC; Garino M; Balbo G
    Can J Surg; 1986 Nov; 29(6):445-6. PubMed ID: 3536050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic use of thymostimulin in HIV-seropositive subjects and with lymphadenopathy syndrome].
    Carcò F; Guazzotti G
    Recenti Prog Med; 1993 Nov; 84(11):756-64. PubMed ID: 8290787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
    Achiron A; Barak Y; Gail M; Mandel M; Pee D; Ayyagari R; Rotstein Z
    Breast Cancer Res Treat; 2005 Feb; 89(3):265-70. PubMed ID: 15754125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ; Curran WJ; Keller SM; Catalano RB; Litwin S; Blankstein KB; Haas N; Campli SN; Comis RL
    Cancer J Sci Am; 1996; 2(2):99-105. PubMed ID: 9166507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling].
    Kamenícek V; Holán P; Franĕk P
    Acta Chir Orthop Traumatol Cech; 2001; 68(1):45-9. PubMed ID: 11706714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy for the treatment of acute appendicitis in children].
    Bulanova AA; Akhanzaripov ZA
    Khirurgiia (Mosk); 1994 Aug; (8):34-6. PubMed ID: 7990319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative treatment with thymostimulin in patients with stomach and colorectal neoplasms. Our experience with 114 cases].
    Ciconi E; Capoluongo R; Balduzzi GF; Balzaretti F; Orecchia C
    Minerva Chir; 1992 May; 47(10):939-40. PubMed ID: 1630687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment for colorectal cancer in patients over 80 years. Short and long term results].
    Capra F; Scintu F; Zorcolo L; Casula G
    Minerva Chir; 2003 Aug; 58(4):515-22. PubMed ID: 14603163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.